Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 3/2018

07.03.2018

Highlights from the 2017 American Heart Association Scientific Sessions in Anaheim, California

verfasst von: Dylan L. Steen

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

The Journal of Thrombosis and Thrombolysis is proud to present the first article in a new section entitled “National and International Meeting Highlights”. Each article in this series will review some of the major studies or guideline updates presented at international conferences. The conferences covered in this series will include the American Heart Association Annual Scientific Sessions, American Society of Hematology Annual Meeting, American College of Cardiology Annual Scientific Session, International Society of Thrombosis and Haemostasis Biennial Congress, and European Society of Cardiology Annual Congress. Although all the exciting presentations at each conference cannot be covered in these articles, we hope this series provides readers with a taste of the ones that may shape guidelines and practice. …
Literatur
1.
Zurück zum Zitat Ridker PM, Thuren ET, MacFadyen JG et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. NEJM 21(12):1119–1131 377)CrossRef Ridker PM, Thuren ET, MacFadyen JG et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. NEJM 21(12):1119–1131 377)CrossRef
4.
Zurück zum Zitat Mazer CD, Whitlock RP, Fergusson DA et al (2017) Restrictive or liberal red-cell transfusion for cardiac surgery. NEJM 30(22):2133–2144 377)CrossRef Mazer CD, Whitlock RP, Fergusson DA et al (2017) Restrictive or liberal red-cell transfusion for cardiac surgery. NEJM 30(22):2133–2144 377)CrossRef
5.
Zurück zum Zitat Cannon CP, Bhatt DL, Oldgren J et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. NEJM 19(16):1513–1524 377)CrossRef Cannon CP, Bhatt DL, Oldgren J et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. NEJM 19(16):1513–1524 377)CrossRef
6.
Zurück zum Zitat Whelton PK, Carey RM, Aronow WS et al (2017) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/AphA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC. https://doi.org/10.1016/j.jacc.2017.11.006 Whelton PK, Carey RM, Aronow WS et al (2017) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/AphA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC. https://​doi.​org/​10.​1016/​j.​jacc.​2017.​11.​006
Metadaten
Titel
Highlights from the 2017 American Heart Association Scientific Sessions in Anaheim, California
verfasst von
Dylan L. Steen
Publikationsdatum
07.03.2018
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 3/2018
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1632-3

Weitere Artikel der Ausgabe 3/2018

Journal of Thrombosis and Thrombolysis 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.